Mustang Bio Interim CFO Eliot Lurier passes away; CEO Litchman named Interim CFO

MUSTANG BIO, INC.

Eliot Lurier, Interim CFO since April 2022, passed away unexpectedly on December 8, 2023.
Board appointed CEO Manuel Litchman, M.D. as Interim CFO, effective December 11, 2023.
Controller Peter Carney appointed Interim Chief Accounting Officer, also effective December 11, 2023.
No new compensation arrangements or employment agreements entered with Litchman or Carney.
Litchman has served as President & CEO since April 2017; Carney has been Controller since August 2021.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Peter Carney

Interim Chief Accounting Officer

MBIO · MUSTANG BIO, INC.

Effective: 2023-12-11
Filed: December 12, 2023, 6:59 PM ET

Also on December 11, 2023, the Board appointed Peter Carney, Controller of the Company, as the Company’s Interim Chief Accounting Officer, effective immediately.

Appointed (interim)

Manuel Litchman

Interim Chief Financial Officer

MBIO · MUSTANG BIO, INC.

Effective: 2023-12-11
Filed: December 12, 2023, 6:59 PM ET

On December 11, 2023, the Board of Directors of the Company (the “Board”) appointed Manuel Litchman, M.D., President and Chief Executive Officer of the Company, as the Company’s Interim Chief Financial Officer, effective immediately.

Departed (interim)

Eliot Lurier

Interim Chief Financial Officer

MBIO · MUSTANG BIO, INC.

Effective: 2023-12-08
Successor: Manuel Litchman
Filed: December 12, 2023, 6:59 PM ET

On December 8, 2023, Eliot Lurier, the Interim Chief Financial Officer of Mustang Bio, Inc. (the “Company” or “Mustang”), passed away unexpectedly.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Carney was appointed as Interim Chief Accounting Officer at MUSTANG BIO, INC..

Action: appointed
Role: Interim Chief Accounting Officer

Exact text from the filing

Also on December 11, 2023, the Board appointed Peter Carney, Controller of the Company, as the Company’s Interim Chief Accounting Officer, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Manuel Litchman was appointed as Interim Chief Financial Officer at MUSTANG BIO, INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On December 11, 2023, the Board of Directors of the Company (the “Board”) appointed Manuel Litchman, M.D., President and Chief Executive Officer of the Company, as the Company’s Interim Chief Financial Officer, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Eliot Lurier departed as Interim Chief Financial Officer at MUSTANG BIO, INC..

Action: passed away
Role: Interim Chief Financial Officer

Exact text from the filing

On December 8, 2023, Eliot Lurier, the Interim Chief Financial Officer of Mustang Bio, Inc. (the “Company” or “Mustang”), passed away unexpectedly.

View on SEC.gov

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-125067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.